2 FORMS OF TRANSFORMING GROWTH-FACTOR-BETA DISTINGUISHED BY MULTIPOTENTIAL HEMATOPOIETIC PROGENITOR CELLS
2 FORMS OF TRANSFORMING GROWTH-FACTOR-BETA DISTINGUISHED BY MULTIPOTENTIAL HEMATOPOIETIC PROGENITOR CELLS
复制标题
DOI:
10.1038/329539a0
复制
发表时间:
1987-10-08
期刊:
影响因子:
64.8
通讯作者:
MASSAGUE, J
中科院分区:
文献类型:
--
作者:
OHTA, M;GREENBERGER, JS;MASSAGUE, J
Type-β transforming growth factors (TGF-βs) are polypeptides that act hormonally to control proliferation and differentiation of many cell types1,2. Two distinct homodimeric TGF-β polypeptides, TGF-β1 and TGF-β2 have been identified which show ˜70% amino-acid sequence similarity3,4. Despite their structural differences, TGF-β1 and TGF-β2 are equally potent at inhibiting epithelial cell proliferation and adipogenic differentiation3. The recent immunohistochemical localization of high levels of TGF-β in the bone marrow and haematopoietic progenitors of the fetal liver5has raised the possibility that TGF-βs might be involved in the regulation of haematopoiesis. Here we show that TGF-β1, but not TGF-β2, is a potent inhibitor of haematopoietic progenitor cell proliferation. TGF-β1 inhibited colony formation by murine factor-dependent haematopoietic progenitor cells in response to interleukin-3 (IL-3) or granulocyte-macrophage colony stimulating factor (GM-CSF), as well as colony formation by marrow progenitor cells responding to CSF-1 (M-CSF). The progenitor cell lines examined were ˜100-fold more sensitive to TGF-β1 than TGF-β2, and displayed type-I TGF-β receptors with affinity ˜20-fold higher for TGF-β1 than TGF-β2. These results identify TGF-β1 as a novel regulator of haematopoiesis that acts through type-I TGF-β receptors to modulate proliferation of progenitor cells in response to haematopoietic growth factors.